tm logo

Monitor this mark

View On USPTO

BRIDGEBIO
Live/Registered
REGISTERED

on 07 Sep 2021

Last Applicant/ Owned by

Bridgebio Pharma, Inc.

3160 Porter Dr.

Palo Alto

CA

94304

Serial Number

90256777 filed on 15th Oct 2020

Registration Number

6480657 registered on 07th Sep 2021

in the Principal Register

Correspondent Address

Jessica L. Rothstein

Jessica L. Rothstein

620 Eighth Avenue

New York, NY 10018

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

BRIDGEBIO

Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders

First Use Date in General

28th Feb 2021

First Use Date in Commerce

28th Feb 2021

Mark Details

Serial Number

No 90256777

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 135012254035

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

07.11.01 -

Bridges

Legal History

Show more

Status DateAction Taken
01st Aug 2023NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
24th Jun 2023CORRECTION UNDER SECTION 7 - PROCESSED
20th Jun 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18th Dec 2022TEAS SECTION 7 REQUEST RECEIVED
07th Dec 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
07th Dec 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07th Dec 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07th Dec 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
07th Dec 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07th Sep 2021REGISTERED-PRINCIPAL REGISTER